Dr Reddy’s launches Roche’s Avastin biosimilar in India Press Trust of India Aug 19, 2019 The company now has six biosimilar products commercialised in India and various emerging markets
Roche’s personalised cancer treatment wins FDA approval Reuters Aug 16, 2019 The treatment, Rozlytrek, is a tyrosine kinase inhibitor that targets patients who must be identified via genetic profiling
